Mortality in Cardiogenic Shock Patients Is Predicted by Pao2/Fio2 (Horowitz Index) Measured on ICU After Venoarterial Extracorporeal Membrane Oxygenation Implantation
OBJECTIVES:. Venoarterial extracorporeal membrane oxygenation treatment in patients with severe cardiogenic shock can cause or aggravate acute lung injury. In our retrospective analysis, we aimed at identifying markers for acute lung injury after arrival on ICU, which predict mortality of those pati...
Guardado en:
Autores principales: | Clemens Scherer, MD, Enzo Lüsebrink, MD, Dominik Joskowiak, MD, Vanessa Feuchtgruber, MDS, Tobias Petzold, MD, Jörg Hausleiter, MD, Sven Peterss, MD, Steffen Massberg, MD, Christian Hagl, MD, Martin Orban, MD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d1c014da5552466a9e94a987c7855e5a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Estimated Pao2: A Continuous and Noninvasive Method to Estimate Pao2 and Oxygenation Index
por: Michaël Sauthier, MD, MBI, et al.
Publicado: (2021) -
ICU Mortality in Patients With Coronavirus Disease 2019 Infection: Highlighting Healthcare Disparities in Rural Appalachia
por: Sunil Sharma, MD, ATSF, et al.
Publicado: (2021) -
Allogeneic Hematopoietic Stem Cell Transplant Infusion During Venovenous Extracorporeal Membrane Oxygenation Support
por: Rayan Qutob, MD, SBIM, FCCM, et al.
Publicado: (2021) -
A Trigger and Response System for Preventing Cardiac Arrest in the ICU
por: Ari Moskowitz, MD, et al.
Publicado: (2021) -
Efficacy and Safety of Vilobelimab (IFX-1), a Novel Monoclonal Anti-C5a Antibody, in Patients With Early Severe Sepsis or Septic Shock—A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase IIa Trial (SCIENS Study)
por: Michael Bauer, MD, et al.
Publicado: (2021)